MIRM Stock Analysis: Buy, Sell, or Hold?
MIRM - Mirum Pharmaceuticals, Inc. Common Stock
$102.19
-9.20 (-8.26%)
▼
5d:
-4.64%
30d:
+6.6%
90d:
-0.89%
BUY
HIGH Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Smart Money Accumulation
MIRM is down 4.6% this week, but smart money is accumulating calls. Top strike: $120 2026-06-18 with 103 OI. Call ratio: 100% View Scanner →
Strength: 7.3/10
Get Alerted When MIRM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called MIRM this week
50% bullish • 1 bearish
50% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MIRM shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: MIRM shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: MIRM is currently trading at $102.19, which is considered slightly high relative to its 30-day fair value range of $93.41 to $105.02. From a valuation perspective, the stock is trading at a discount (Forward PE: -183.1) compared to its historical average (185.2). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MIRM is in a strong uptrend. Immediate support is located at $88.34, while resistance sits at $114.99. Short-term momentum is weak, with the stock down 8.3% recently.
Market Sentiment: MIRM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $146.36 (+43.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MIRM is in a strong uptrend. Immediate support is located at $88.34, while resistance sits at $114.99. Short-term momentum is weak, with the stock down 8.3% recently.
Market Sentiment: MIRM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $146.36 (+43.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$93.41 -
$105.02
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
76.2%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.3%)
- BULLISH: Trading 43.2% below Wall St target ($146.36)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$93.41 -
$105.02
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$88.34
Resistance Level
$114.99
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-183.13
Wall Street Target
$146.36
(+43.2%)
Revenue Growth (YoY)
43.3%
Profit Margin
-140.2%
PE vs Historical
-183.1 vs 185.2
CHEAP
Share & Embed Analysis
Last updated: May 18, 2026 8:19 AM ET
Data refreshes hourly during market hours. Next update: 9:19 AM
Data refreshes hourly during market hours. Next update: 9:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MIRM showing a specific setup today?
Insider Activity (6 Months)
1
Buys
18
Sells
Net
INSIDERS SELLING
Recent Transactions
Eric Bjerkholt
SELL
7287 shares
2026-03-16
Joanne Quan
SELL
7287 shares
2026-03-16
Jolanda Howe
SELL
4732 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 53 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 61 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 58 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 57 HOLD |
Advanced MIRM Option Strategies
Professional options setups generated by AI based on today's MIRM price and gamma walls.
